noon glp-1 🎉A new approach to weight loss! 🎉 medications are changing the landscape of weight management. Join us for FREE classes to learn more about these medicines., ➡️3 classes in total Noom Launches GLP-1 Microdosing for

Withdrawal from GLP-1 Injections understanding how to discontinue weight loss medicines safely and what to expect.

Alexandra Sowa discusses the surge in GLP-1 use, concerns over prescriptions without in-person visits and how ChatGPT health may help patients get faster treatment.

Diabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.

Dr Reddys launches oral semaglutide biosimilar tablets, offering broader access to diabetes and weight-loss therapies in India.

New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes

The GLP-1 Exit Plan: The first step-by-step guide to life after GLP-1s-using personalized nutrition, mindset, and your DNA to stay free for life